A small-volume parenteral formulation of NB1011, an enzyme-catalyzed therapeutic activation compound, was successfully developed for intravenous administration.
Manoj Maniar, PhD
Advertisement
Manoj Maniar, PhD, is senior director at the formulation and drug delivery group, BioSciences Division, SRI International.
Articles by Manoj Maniar, PhD
Advertisement
Latest Updated Articles
- Formulation Development of a Nucleotide Phosphoramidate
Published: June 2nd 2003 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Audits, Inspections, and CDMOs
2
The Regulatory Crucible: Risk, Resource Drain, and the Hidden Trade-Offs of the CNPV Pilot Program
3
Ready or Not: Biopharma Alignment for CNPV’s Rapid Review
4
Molecular Dynamics and Quantum Calculations: AAPS Thermo Fisher Interview, Part Two
5
